血液透析

1.Objective To observe effects of hemodiafiltration(HDF) and hemodialysis(HD)on uremic encephalopathy(UE).

观察血液透析滤过(HDF)及血液透析(HD)对尿毒症脑病疗效。

2.The method basically has blood dialytic with peritonaeum dialytic two kinds.

方法主要有血液透析和腹膜透析两种。

3.To observe the influence of hemodiafiltration(HDF) on cardiovascular stability of older hemodialysis(HD) patients.

观察血液透析滤过(HDF)对老年透析患者心血管稳定性影响。

4.Objective To assesses the clinical value of tumor markers in haemodialysis patients and uremic patients.

摘要 摘要 ：解血液透析和尿毒症对肿瘤志物水平影响。

5.Methods Observing 12 cases with hematodialysis by artificial blood vessel internal fistula, and giving nursing according internal fistula.

方法观察12例造血管内瘘行血液透析患者,针对其内瘘情况进行护理。

6.Conclusion The hyponatremia patients can use hemodialysis when dieresis had no effect, combine heart failure or hypervolemia.

结论低钠血症患者如果利尿效果不佳或合并有心力衰竭或高血容量时,可以考虑血液透析治疗。

7.Objective To perspectively evaluate the prevalence and clinical characteristics of acquired cystic kidney disease and renal cell carcinoma in hemodialysis patients.

提高对长期血液透析患者获得性肾囊肿及肾细胞癌发病和临床特点认识。

8.Objective To investigate the factor relateted to the prognosis in HFRS patients with ARF oliguresis stage and the applied chance of hemodiaglysis in HFRS patients.

探讨影响出血热病急性肾衰少尿期预后因素及血液透析在出血热病中应时机。

9.Objective To investingate the clinical effect of Shenkang injection in treating chronic renal failure and control process of it,slowing down and decreasing the numbers of dialyses.

观察肾康注射液治疗慢性肾功能衰竭疗效,为控制慢性肾衰患者肾衰进程而延缓进行血液透析提供一个好方法。